Development of Czech National Stroke Guidelines
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Article in Periodical |
| Magazine / Source | International Journal of Evidence-Based Healthcare |
| MU Faculty or unit | |
| Citation | |
| Web | http://dx.doi.org/10.1097/XEB.0000000000000190 |
| Doi | http://dx.doi.org/10.1097/XEB.0000000000000190 |
| Keywords | aortic valve disease; atrial fibrillation; atrial septal defect; clinical practice guidelines; endocarditis; flutter; intravenous thrombolysis; ischaemic stroke; mechanical thrombectomy; secondary prevention |
| Description | Despite a significant transformation of ischaemic stroke management, it remains one of the leading causes of death, disability, functional impairment and cognitive deficits. With the advent of intravenous thrombolysis and mechanical thrombectomy, stroke is not an untreatable disease, mostly occurring in older people, any more. The most common cause of cardioembolic strokes is atrial fibrillation or flutter and atrial fibrillation is the most prevalent arrhythmia. The aim of this short communication is to describe the methodology of the Czech stroke guidelines development. High-quality 2017 Australian Stroke Foundation stroke guideline was considered for adaptation and a new guideline was developed and disseminated. |